ARTICLE | Clinical News
RF 1051: Will start this week a Phase I/II trial in severe chronic obesity in 8-16 patients whose levels of the undisclosed steroid are low. The dose-escalation
August 7, 1995 7:00 AM UTC
SuperGen Inc. Product: RF 1051, a naturally occurring steroid hormone Indication: Obesity Status: Will start this week a Phase I/II trial in severe chronic obesity in 8-16 patients whose levels of the...